Method and composition for decreasing the psychotomimetic side effect and addictive disorder of ketamine
The present invention relates to a method for decreasing the abuse liability and psychotomimetic side effects and enhancing the antidepressant-like effects of ketamine by the combination of ketamine with a methyl glycine derivative. The combination can be applied in the treatment of treatment-resistant depression/bipolar disorders, anxiety disorders and pain.
Administration with recombinant fragment of human SP-D (rfhSP-D) in t he diagnosis and treatment for chronic obstructive pulmonary disease
Ultrahigh-Sensitive Detection Platform Powered by Semiconductor-based Biosensor for the evaluation of Treatment on Acute Myeloid Leukemia
Integration of intelligent transcranial magnetic stimulation and language -cognitive VR training system
The composition of immunoglobulin IgY in the therapeutic/prevention of norovirus infection
Technology maturity：Prototype
Exhibiting purpose：Display of scientific results
Trading preferences：Negotiate by self
Coming soon!